SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
Incidence Assays
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
6 of
6
|
Discussion Leader
Christine M. Rousseau
Bill and Melinda Gates Foundation, Seattle, WA, United States
Performance of the Limiting-Antigen Avidity EIA for Use With Dried Blood Spot Specimens
Erin K. Rottinghaus
Centers for Disease Control and Prevention, Atlanta, GA, United States
Incorrect Identification of Recent HIV Infection Using a LAg-Avidity Assay in Adults in the US
Andrew F. Longosz
Laboratory of Immunoregulation, Division of Intramural Research, National Insitutes of Health, Baltimore, MD, United States
The Impact of HIV Subtype On Specificity of Cross-Sectional HIV Incidence Assays in Rakai, Uganda
Andrew F. Longosz
NIAID, National Insitutes of Health, Baltimore, MD, United States
Independent Evaluation of Predicate Incidence Assays for HIV Surveillance
Alex Welte
The South African DST/NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
6 of
6
|
